| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.2 | 0.005 |